Biotech Rips On Topline Analysis

By: Tomas Ronolski - AllPennyStocks.com News

Tuesday, February 11, 2025

A biotech company is turning heads so far during Tuesday’s session after it shared topline analysis of its Phase 2a dose-ranging trial of LP-310, a liposomal-tacrolimus oral rinse formulation of LP-10 being developed to treat oral lichen planus (OLP), according to a press release.

Traders rushed to scoop up shares of Lipella Pharmaceuticals Inc. (Nasdaq:LIPO) at the open, pushing this micro cap up to $4.69/share (+5377%) at the early session high. This move was a strong confirmation of the recent breakout from its multi-month downtrend.

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.

Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

The Legacy Product Is Shrinking. A New One is Growing 250%

Scandium Explorer Jumps 15% on Shift from Metallurgical Sampling to Extension Drilling

Environmental Approval Sparks 24% Rally for Coastal Peru Copper-Molybdenum Target

Most Popular

{{ index + 1 }}

AllPennyStocks.com Favorites

A High-Conviction Healthcare Stock With A Favorable Risk-Reward Setup

Enable Free Access to Unlock Up to Two Articles Per Month.

Every AI Data Center Needs Water. This Microcap Just Signed a Research License With NASA

Enable Free Access to Unlock Up to Two Articles Per Month.

Nasdaq listed, AquaBounty Technologies Inc. looks ready to rally as the stock exhibited a Golden Cross (50 DMA / 200 DMA). With a closing price of $1.37, we continue to monitor this technical signal for future potential upward movement.

Monday's hottest penny Stock on the Canadian Securities Exchange was Pharmadrug Inc., which gained 100.00%, closing the day at $0.01.

Monday's hottest penny Stock on the Nasdaq was Signature Bank, which gained 35.14%, closing the day at $0.50.

Is This Junior Gold Miner Ready to Explode Higher?

Enable Free Access to Unlock Up to Two Articles Per Month.

This Junior Gold Miner Is Breaking Its Downtrend as Metals Regain Momentum

Enable Free Access to Unlock Up to Two Articles Per Month.

Free Membership Has Its Perks!

By entering your email address, you agree to AllPennyStocks.com’s disclaimer and privacy policy.

Register via:

You understand that AllPennyStocks.com and its affiliates may use your address to send updates, ads and offers.

By clicking on the "Start Viewing AllPennyStocks.com Pro Articles" button below, you are confirming that you understand and accept that the content we are showing you is not meant to be used as financial advice. This content is merely for educational purposes and shows our readers real-time examples of trading strategies based on technical and fundamental analysis principles, along with stock market commentary.

Investing in stocks is risky stuff, trust us on that one, and past performance may not be indicative of future performance.

We want everyone to enjoy this information for its educational value, and we remind everyone that we are not liable for losses or damages of any kind from trading based on our information. The only thing we will recommend is to consult with a financial advisor prior to making any trades.

With that said, if we're on the same page here and you agree to our disclaimer, click the button below and enjoy all of our AllPennyStocks.com Pro content.

© Copyright 2026 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.